Abstract
Background: In view of liver support systems, implantation of isolated hepatocytes or hepatocyte-like cells is increasingly under discussion. We investigated the efficacy of implantation of different hepatic cell lines in a model of surgically induced liver failure. Material/Methods: In a model of acute liver failure after subtotal hepatectomy, cells of different origin were injected into the spleen of Wistar rats 24 hours prior to surgery. Following an observation period of 5 days, postoperative weight, signs of encephalopathy, and animal survival were recorded. Three groups of animals were compared: Injection of A) 1ml 0,9 % saline solution, B) 24 × 106 rat hepatocytes, C) 24 × 106 NeoHep-Cells. At the end of the observation period, blood was collected for laboratory analysis. Results: Out of 79 animals, 4 of 14 in group A (29 %), 13 of 18 in group B (72 %), and 11 of 22 in group C (50 %) survived the observation period. In group B and C, we observed less frequently signs of postoperative encephalopathy, as well as earlier recovery in terms of weight increase when compared to animals in group A. With respect to laboratory findings at day 5 after surgery, no statistically significant differences were observed. Discussion: Hepatocyte transplantation is a practicable and successful treatment option in case of liver insufficiency since implantation of hepatocyte-like cells (NeoHep-Cells) or primary rat hepatocytes had an improving effect on survival.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63: 559–569
Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W, Brulport M, Gabelein G, Schormann W, Schulze M, Ellis E, Kraemer M, Nocken F, Fleig W, Manns M, Strom SC, Hengstler JG (2006) Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 45: 144–159
Ruhnke M, Nussler AK, Ungefroren H, Hengstler JG, Kremer B, Hoeckh W, Gottwald T, Heeckt P, Fandrich F (2005) Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 79: 1097–1103
Ohashi K, Park F, Kay MA (2001) Hepatocyte transplantation: clinical and experimental application. J Mol Med 79: 617–630
Hutchinson JA, Riquelme P, Wundt J, Hengstler JG, Fändrich F, Ungefroren H, Clement B (2007) Could treatment with neohepatocytes benefit patients with decompensated chronic liver disease? Am J Hematol 82: 947–948
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Gaebelein, G. et al. (2008). Transplantation von Hepatozyten ähnlichen Zellen (NeoHep-Cells) verbessert das Überleben bei akutem Leberversagen. In: Arbogast, R., Schackert, H.K., Bauer, H. (eds) Chirurgisches Forum 2008. Deutsche Gesellschaft für Chirurgie, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78833-1_64
Download citation
DOI: https://doi.org/10.1007/978-3-540-78833-1_64
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78821-8
Online ISBN: 978-3-540-78833-1
eBook Packages: Medicine (German Language)